AAAAAA
Results:
1-11
|
Results: 11
Authors:
Egg, R
Reindl, M
Deisenhammer, F
Linington, C
Berger, T
Citation: R. Egg et al., Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis, MULT SCLER, 7(5), 2001, pp. 285-289
Authors:
Deisenhammer, F
Reindl, M
Berger, T
Citation: F. Deisenhammer et al., Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against TFN-beta 1b, J INTERF CY, 21(3), 2001, pp. 167-171
Authors:
Reindl, M
Knipping, G
Wicher, I
Dilitz, E
Egg, R
Deisenhammer, F
Berger, T
Citation: M. Reindl et al., Increased intrathecal production of apolipoprotein D in multiple sclerosis, J NEUROIMM, 119(2), 2001, pp. 327-332
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, HP
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Deisenhammer, F
Freimuller, M
Hartung, HP
Kollegger, H
Kristoferitsch, W
Lassmann, H
Markut, H
Vass, K
Altenkirch, H
Boese, J
Gass, A
Gehlen, W
Goebels, N
Haas, J
Haferkamp, G
Heidenreich, F
Heitmann, R
Hemmer, B
Hohlfeld, R
Janzen, RWC
Jugelt, E
Kolmel, W
Konig, N
Kowitzsch, K
Manegold, U
Melms, A
Mertin, J
Petereit, HF
Pette, M
Pohlau, D
Poser, S
Sailer, M
Schmidt, S
Schock, G
Schulz, M
Seidel, D
Stangel, M
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, UK
Zipp, F
Zschenderlein, R
Bayas, A
Chan, A
Flachenecker, P
Gold, R
Grauer, O
Jung, S
Kallmann, B
Leussink, V
Maurer, M
Rieckmann, P
Toyka, KV
Weilbach, FX
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157
Authors:
Stockhammer, G
Poewe, W
Burgstaller, S
Deisenhammer, F
Muigg, A
Kiechl, S
Schmutzhard, E
Maier, H
Felber, S
Schumacher, P
Gunsilius, E
Gastl, G
Citation: G. Stockhammer et al., Vascular endothelial growth factor in CSF - A biological marker for carcinomatous meningitis, NEUROLOGY, 54(8), 2000, pp. 1670-1675
Authors:
Deisenhammer, F
Mayringer, I
Harvey, J
Dilitz, E
Gasse, T
Stadlbauer, D
Reindl, M
Berger, T
Citation: F. Deisenhammer et al., A comparative study of the relative bioavailability of different interferon beta preparations, NEUROLOGY, 54(11), 2000, pp. 2055-2060
Authors:
Kiechl, S
Willeit, J
Deisenhammer, F
Poewe, W
Citation: S. Kiechl et al., Sensory predominant neuropathy with GM(1) antibodies, conduction blocks, and orbital pseudotumour, J NE NE PSY, 68(2), 2000, pp. 252-253
Authors:
Deisenhammer, F
Fazekas, F
Strasser-Fuchs, S
Nahler, G
Mamoli, B
Citation: F. Deisenhammer et al., Intravenous immunoglobulins in multiple sclerosis: Results of the Austrianimmunoglobulin in multiple sclerosis (AIMS) trial, INFUSIONSTH, 26, 1999, pp. 42-47
Authors:
Kaser, A
Deisenhammer, F
Berger, T
Tilg, H
Citation: A. Kaser et al., Interferon-beta(1b) augments activation-induced T-cell death in multiple sclerosis patients, LANCET, 353(9162), 1999, pp. 1413-1414
Authors:
Deisenhammer, F
Reindl, M
Harvey, J
Gasse, T
Dilitz, E
Berger, T
Citation: F. Deisenhammer et al., Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies, NEUROLOGY, 52(6), 1999, pp. 1239-1243
Authors:
Reindl, M
Linington, C
Brehm, U
Egg, R
Dilitz, E
Deisenhammer, F
Poewe, W
Berger, T
Citation: M. Reindl et al., Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study, BRAIN, 122, 1999, pp. 2047-2056
Risultati:
1-11
|